Herbal Supplements

With the new medical reform policy, the national essential drug system, officially announced the introduction of a series of favorable policies, China Medicine Revive the growth momentum of foreign trade.

24 Feb

Chinese imports of China's foreign trade was sluggish trend of rising exports

Posted in on 24.02.11

With the new medical reform policy, the national essential drug system, officially announced the introduction of a series of favorable policies, China Medicine Revive the growth momentum of foreign trade. 1 August this year, medical health products import and export amounted to 33.175 billion U.S. dollars, up 2.3%. Among them, Import 12.689 billion U.S. dollars, up 14.08%; exports 20.486 billion U.S. dollars, down 3.85% year on year. Chinese trade surplus of 7.797 billion U.S. dollars, up 22 percent reduction.


Imports rose contrarian In The new medical reform plan Official purposes, "Essential Drugs List" issued favorable policies such as driving, I am a strong rebound in imports of medicine and health products, medical foreign trade growth this year as supporting the main force. As of the end of August, imports increased over last year 1.5 billion, of which 2 were achieved in August rose. Chain, in addition to 5,8 two months fell slightly, the other months have soared, especially in July, the import amounted to 1.82 billion U.S. dollars, a new record high, fully reflects the strong market demand. Import prices in August 1 shows a more obvious "W"-type volatilities into the June rate of decline after the shock, become stable.


Dominant import Western products across the board gains across the board, which Shenghua Yao grew 23.48% to the performance of the most eye-catching. Plant Extract Achieved staggering 112.3% increase, has rapidly risen to such products imports of Chinese medicine class second position. In addition, Medical Devices Products EADS were mixed in a large environment, health and healing products has plummeted 13 percentage points. Export out of the doldrums yet


By the foreign economic situation remains unclear, especially in weak market demand, operating risk is still great and the countries have introduced trade protection policies, China's pharmaceutical exports face greater obstacles. Chain, since February began, the overall situation of Chinese exports remained the growth trend, but the same period last year, the export situation has not yet broken free from the drastic shrinkage of the previous stage of the unfavorable situation in the past 8 months, only two months over the same period the level of .


Proportion of total export Liucheng not weakness medicine products unchanged, exports fell by 8.56%. Of which: Western drug ingredients The overall demand for drugs subject to the international market shrinking, the upstream chemicals prices and other factors, the trend remains in the doldrums, down 12.1%. Average price of the chain, up both fell down leading to the main exports of western type. Fortunately, in the Western categories of export Pudie situation, several of the traditional advantages of our products, such as dimension C, erythromycin, and heparin have also experienced a rise in exports of contrarian situation, to a certain extent, resisted the API The downward trend in exports. Entered in August, China Shenghua Yao, Western medicine exports to continue the momentum of rise somewhat contrarian decay, but remain up, as of August, exports reached 845 million U.S. dollars respectively, and 7.6 billion U.S. dollars, up 52.78 percent to Shenghua Yao to consolidate its strong momentum in the Western categories of export products to the second position.


On Chinese exports decline in contributions to prevent the largest medical device products, this year has maintained good growth momentum. 1 August total exports 7.245 billion U.S. dollars, up 4.43%. 5 categories of specific products, dental equipment and materials, medical supplies, disposable supplies and hospital equipment diagnosis and treatment of a gain, dental equipment and materials and equipment to rise 25 percent year on year, "thriving", dressing up to 12.55% of the gain in rankings Second, once the diagnosis and treatment supplies and hospital equipment, stable gains were maintained up 5.18% and 3.69% gain, but a substantial decline in exports of health care and rehabilitation products, fell to 7.89%.


Chinese exports in the overall bullish class situation, mixed concrete products. Extract exports 414 million U.S. dollars, up 18.41%, two indicators were ranked first in exports of Chinese medicine class, is the main force driving growth. Health care products exports 055 million U.S. dollars,

About the Author:
I am an expert from Frbiz Site, usually analyzes all kind of industries situation, such as automotive fuse , cartridge fuses.

Author: tianli